Skip to main content
Home
About the fund
The Team
Portfolio
News & Insights
Information
How to apply
FAQs
Contact
Guide to Hopin
Search
You are here
Home
»
News & Insights
News & Insights
Reset
Sector
All
Life Sciences
Physical Sciences
News
NovalGen receives CTA approval to start a Phase 1/2 first in human study
NovalGen receives CTA approval to start a Phase 1/2 first in human study
April 07, 2021
News
Achilles Therapeutics Announces Pricing of Initial Public Offering
London, UK 30 March 2021 – Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing...
March 31, 2021
News
MedNous interviews Professor Amit Nathwani
MedNous recently interviewed Professor Amit Nathwani, Chief Executive Officer of UCLTF portfolio company NovalGen. He shares his...
March 25, 2021
Investment
Intrinsic closes £1.35m seed funding round to prototype next generation memory devices
Memory innovator Intrinsic Semiconductor Technologies Ltd (“Intrinsic”) has announced the close of a £1.35m seed funding round...
March 22, 2021
Insights
International Women’s Day 2021 – Meet Leigh Brody, UCLTF Investment Manager
To celebrate International Women's Day, we interviewed Leigh Brody, UCLTF Investment Manager.
March 08, 2021
Investment
Renowned Geneticist Philip Beales Launches Axovia Therapeutics to Develop Transformative Medicines for Ciliopathies
Axovia, an innovative gene therapy company developing disease-transformative medicines for ciliopathies, is a majority-owned...
February 25, 2021
News
NovalGen enters strategic partnership with HALIX B.V. to manufacture clinical trial materials
London, United Kingdom and Leiden, The Netherlands, February 22nd 2021 – NovalGen Ltd. (“NovalGen”), a biopharmaceutical company...
February 22, 2021
Insights
Why you should consider manufacturing from the start of the biotech R&D process
Simon Goldman, February 2021 - One of the most important, yet under-appreciated aspects of biotech commercialisation is the...
February 22, 2021
Investment
Quell Therapeutics Expands Series A Financing to $84 Million
Quell Therapeutics Ltd (“Quell”), a biotechnology company developing engineered T regulatory (Treg) cell therapies, today...
February 11, 2021
Insights
UCL Technology Fund talks to the PanAngium team
UCL Technology Fund's Simon Goldman talks to Academic Co-Founders of PanAngium, Professors Steve Moss and John Greenwood.
January 08, 2021
Insights
Platform technologies: going deep to go wide
Biomedical platform technologies are appealing because they can create impact (and therefore revenues) in multiple markets or...
January 04, 2021
Investment
Phasecraft announces largest seed funding round for a UK quantum computing company and new technology breakthroughs
On the back of new quantum algorithm breakthroughs, Phasecraft has today closed a record seed round for a quantum computing...
December 11, 2020
Insights
UCL Technology Fund talks to co-founders of Echopoint about all things startups, fundraising and VC
David Grimm, Director at the UCL Technology Fund talks to co-founders of Echopoint Malcolm Finlay and Adrien Desjardins.
December 02, 2020
Investment
Third Space Learning raises £4.3m Series-A extension and announces a commercial partnership with China’s NetDragon to accelerate plans for international expansion.
Third Space Learning (TSL), the UK’s leading online tutoring company, has completed a £4.3m funding extension from existing...
November 27, 2020
Investment
Nozzle.ai raises $2.6m to accelerate adoption of AI platform with brands and sellers on Amazon
Nozzle.ai, an eCommerce and advertising optimisation platform for Amazon, has raised $2.6 million (£2 million) in funding from...
November 18, 2020
Insights
UCL Technology Fund and Orchard Therapeutics: from idea to Nasdaq IPO and beyond
Dr Simon Goldman, interviews CEO of Orchard Therapeutics, Professor Bobby Gaspar.
October 27, 2020
Insights
An evolution in early stage gene therapy funding models
October 27, 2020
News
We are recruiting a Life Sciences Investor for the UCL Technology Fund
We are recruiting a new Investment Manager to join the Life Sciences team within UCL Technology Fund.
September 23, 2020
News
Freeline Therapeutics makes its NASDAQ debut
Freeline Therapeutics Holdings plc (“Freeline”), a UCL Technology Fund portfolio company, has made its debut on NASDAQ in the...
August 07, 2020
Investment
Bramble energy secures significant new capital to accelerate its unique fuel cell deployment
Bramble Energy, the world’s most scalable hydrogen fuel cell company has raised a £5m Series A round. BGF led the round and was...
August 04, 2020
News
UCL Technology Fund announces first close of £100m Fund 2
UCL Technology Fund (UCLTF), managed by AlbionVC in collaboration with UCL Business (UCLB) (the university’s commercialisation...
August 03, 2020
Investment
Humanloop raises funding to teach AI to learn from humans faster
Humanloop, a game changing UCL spinout, has attracted investment from UCL’s Technology Fund (UCLTF). Based on the world-leading...
July 29, 2020
News
UCL engineering cancer antibody therapies for Covid-19
UCL’s Cancer Institute is repurposing a sophisticated antibody engineering approach, funded by the UCL Technology Fund (UCLTF),...
June 18, 2020
Investment
Epsilogen Announces £3m Series A2 financing and licences MOv18 IgE, an anti-folate receptor alpha IgE antibody from King’s College London
Epsilogen Ltd (formerly known as IGEM Therapeutics), a global leader in the development of immunoglobulin E (IgE) antibodies to...
April 20, 2020
Investment
AstronauTx secures UCLTF investment for dementia therapeutics
AstronauTx Ltd, a biotech company developing new medicines designed to restore the normal behaviour of astrocytes for the...
March 24, 2020
News
Portfolio company Astroscreen featured in the Evening Standard
As the UK gears up for a potential election, there are concerns over the role disinformation will play in democracy
October 17, 2019
News
Quell Therapeutics makes FierceBiotech's 2019 Fierce 15
The list highlights biotech companies whose hard work and cutting-edge research aims to stop disease in its tracks.
September 23, 2019
Investment
Echopoint raises £2.8m to address the ‘grey zone’ of heart disease treatment
Echopoint Medical Ltd, a spinout company from UCL, has raised £2.8m to develop optical sensing technology to help heart disease...
September 16, 2019
Insights
Why we Invested in Quantum Computing start-up Phasecraft
There has been a leap in excitement about quantum computing in the last year thanks to the emergence of a new class of quantum...
September 09, 2019
Investment
Achilles Therapeutics raises £100m in Series B
Achilles Therapeutics (“Achilles”), a bio-pharmaceutical company developing personalised cancer immunotherapies, today announces...
September 04, 2019
News
Orchard Therapeutics Announces Update from POC Study of OTL-203
Orchard Therapeutics announced data from an ongoing proof-of-concept clinical trial evaluating the safety and efficacy of OTL-203...
September 04, 2019
Insights
UCL’s Centre for Amyloidosis and Acute Phase Proteins published in the Journal of Medicinal Chemistry
Ground-breaking work by Prof Alessandra Corazza, Prof Sir Mark Pepys, Prof Vittorio Bellotti and colleagues of the Wolfson Drug...
August 27, 2019
Insights
Funding academic innovations in advanced therapies: an interview with Simon Goldman
Simon Goldman, Investment Manager for UCLTF, talks to RegMedNet about funding academic innovation
August 01, 2019
Insights
2019 Brochure
Featuring fund highlights from the past year
June 20, 2019
Insights
Andrew Elder on healthtech investing
Andrew Elder talks to HS. about his journey from brain surgeon to venture capitalist, the history of healthtech investing and how...
June 18, 2019
News
UCL Technology Fund Showcase 2019
We would like to thank everyone who attended the 2019 UCL Technology Fund showcase. We hope the event provided some insight on...
June 17, 2019
News
Hazy wins 'Best Innovation in Data Protection & Privacy'
Hazy wins 'Best Innovation in Data Protection & Privacy' at the 2019 CogX awards.
June 11, 2019
Investment
Fund leads £750k investment in Phasecraft
The UCL Technology Fund led a £750k investment into Phasecraft, a pioneering quantum computing company, along with co-investors...
May 29, 2019
Investment
UCLTF completes £1m investment into Quell Therapeutics as part of £35m Series A round
UCLTF £1m investment into Quell Therapeutics is part of a £35m Series A round led by Syncona
May 20, 2019
News
UCLTF nominated for 'Investment Unit of the Year'
We are delighted to announce that the UCL Technology Fund has been nominated for Investment Unit of the Year by Global University...
April 30, 2019
Investment
Odin Vision scales up its cancer detection technology
Innovative medtech company Odin Vision is to scale up its pioneering cancer detection technology thanks to an investment round...
April 30, 2019
Investment
Astroscreen raises $1m to detect social media manipulation
UK-based start-up Astroscreen has secured $1M in initial funding to progress its pioneering technology which identifies carriers...
April 18, 2019
News
Data Supports Achievement of Proof-of-Concept Milestone for OTL-300
Orchard Therapeutics has announced the achievement of clinical proof-of-concept based on data from the trial of OTL-300, for the...
April 16, 2019
News
Orchard Therapeutics achieves 100% survival rate during trial treatment for ADA-SCID
Orchard Therapeutics, a commercial-stage biopharmaceutical company, presented their two-year follow-up data in 20 patients from...
February 28, 2019
News
Hazy included in Forbes '15 Machine Learning Companies To Watch In Europe'
Hazy has been listed by Forbes as one of the Top 15 European Machine Learning companies to watch.
December 03, 2018
Investment
IGEM Therapeutics Announces Final Close of £5m Series A Financing Round
New investors Alsa Holdings and UCL Technology Fund join Epidarex Capital Proceeds will allow IGEM to continue development of IgE...
November 30, 2018
News
Orchard Therapeutics announces closing of $225 Million Initial Public Offering
Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through...
November 05, 2018
Investment
UCL spin-out Hazy adds $1.8 million in seed funding
Hazy, the London-based AI company enabling ethical, effortless and GDPR-compliant data sharing for responsible businesses, has...
August 01, 2018
News
UCL Technology Fund investment MeiraGTx raises $75m at IPO
MeiraGTx is its first UCLTF investment to IPO
July 24, 2018
Exit
Bloomsbury AI joins the Facebook Team in London
UCL Technology Fund is very proud to have backed Bloomsbury AI and we are delighted that they are joining the Facebook team.
July 04, 2018
Investment
Matr raises £4.75 million for AI teaching platform
Matr, the online teaching platform, has announced it has closed a £4.75 million Series A investment round led by the UCL...
June 21, 2018
News
Freeline secures over £88 million of funding
Freeline Therapeutics announces today that it has raised over £88 million of new capital in a Series B financing round
June 19, 2018
Insights
UCL Technology Fund Showcase 2018
The inaugural UCL Technology Fund Showcase, held at Digital Catapult, brought together two years of investing in world-leading...
May 24, 2018
Investment
UCL Technology Fund invests in cell therapy company Glialign
The UCL Technology Fund, UK Innovation & Science Seed Fund, alongside support from Innovate UK, have invested in UCL spinout...
May 03, 2018
Investment
UCL Technology Fund and ParkWalk invest in adtech machine learning company MediaGamma
The UCL Technology Fund has invested in MediaGamma, the predictive analytics software company, as part of a £2m round in...
February 26, 2018
Investment
UCL Technology Fund has approved investment of up to £1m in the development of a gene therapy for p47-CGD
The UCL Technology Fund has approved an investment of up to £1m to support the development of a gene therapy for p47phox-...
April 11, 2017
Investment
UCLTF fund drug development platform Canbex for the treatment of multiple sclerosis
Canbex was established to develop the VSN compound series, a drug development platform with potential applications in a wide...
January 16, 2017
News
Orchard Therapeutics launches with £21-million series A funding round
Orchard Therapeutics has secured £21-million in Series A financing led by F-Prime with UCLTF. Orchard Therapeutics is a...
May 03, 2016
News
Albion to Manage the UCL Technology Fund
Albion Capital, one of the largest independent venture capital investors in the UK is to manage and administer the newly launched...
January 18, 2016
